Medical AI company Lunit said Monday that a research paper that predicted immunotherapy's effectiveness using Lunit SCOPE IO, an AI biomarker platform, has been published in the Journal for Immunotherapy of Cancer (JITC), the official journal of the Society for Immunotherapy of Cancer (SITC).Founded
Celltrion said Monday that Health Canada has approved an additional indication for the company’s autoimmune disease treatment Remsima SC (infliximab) -- Zymfentra in the U.S. -- for inflammatory bowel disease (IBD).IBD is a chronic, incurable intestinal disease in which the immune system targets the
VUNO said it has entered into a strategic partnership with DRGEM to embed VUNO's advanced AI solutions into DRGEM's X-ray systems.Under the agreement, VUNO will supply its AI-based thoracic X-ray interpretation assistant solution, VUNOMED Chest X-ray, to DRGEM.VUNOMED Chest X-ray stands out as an AI
The Korean government has compelled medical schools to submit the personal information of representatives of medical school students who have pledged to embark on a collective leave of absence this week, as revealed in a document obtained by Korea Biomedical Review. The Korean Medical Student Associ
In recent years, Korea's market for pediatric growth hormone treatments has witnessed a significant surge, with non-reimbursable treatments accounting for 90 percent of the total prescriptions. According to IQVIA, a drug market research firm, the pediatric growth hormone treatment market grew to 238
A petition was posted on the National Assembly website on Wednesday, calling for the insurance coverage of Besremi (rofeginterferon alfa-2b), a new drug to treat patients with chronic myeloproliferative blood cancer like polycythemia vera, essential thrombocythemia, and myelofibrosis."I am petitioni
The number of patients with “sudden deafness,” a condition in which a person suddenly loses the ability to hear sound for no particular reason, is increasing rapidly in Korea.According to data from the Health Insurance Review and Assessment Service (HIRA), the number of sudden deafness patients incr
A research team at Yongin Severance Hospital has demonstrated the effectiveness of ChatGPT, specifically the GPT-4 model, in accurately predicting cardiovascular diseases.GPT-4, the latest iteration of the ChatGPT series developed by OpenAI, has previously garnered attention for passing the United S
Hanmi Pharm and GC Biopharma have gotten on track to develop a new treatment for Fabry disease with longer-lasting effects than existing treatments.Hanmi Pharm and GC Biopharma presented two posters on the results of nonclinical studies of LA-GLA (code name HM15421/GC1134A), a candidate for Fabry di
Daewoong Pharmaceutical's Fexuclue is expanding globally as fast as it is effective.Daewoong said Friday that its gastroesophageal reflux disease (GERD) treatment, Fexuclue, has entered or is about to enter the market in 24 countries, including Korea, in just one year and six months since its launch
Interns and residents at Korea’s "Big Five" hospitals have decided to submit their resignations by Monday and stop working from Tuesday.Park Dan, head of the Korean Intern and Resident Association (KIRA), said the association came to this conclusion after discussions with representatives of the trai
Lunit announced a record-breaking revenue of 25 billion won ($21 million) for 2023, marking an 80.9 percent increase from 13.8 billion won a year earlier, thanks to a continued expansion of overseas sales of medical AI solutions. Last year, the Kosdaq-listed company posted an operating loss of appro
In a controversial move, the Korean government announced a plan to increase the admission quota for medical schools by 2,000 students on Feb. 6, sparking fierce opposition from the medical community, including the Korean Medical Association (KMA) and other healthcare organizations.The medical commun
Gradiant Bioconvergence said Thursday that it has entered into a research collaboration agreement with U.S. messenger ribonucleic acid (mRNA) therapeutics developer Strand Therapeutics to develop next-generation mRNA therapeutics.Under the agreement, the companies will collaborate on developing a fo
JW Pharmaceutical said Wednesday that the U.S. Drug Safety Monitoring Board (DSMB) has positively reviewed top-line results from its multinational phase 3 clinical trial of Epaminurad (codenamed URC102) for gout and recommended continuing the trial.On Jan. 31, the DSMB, comprised of U.S. rheumatolog
LifeSemantics said Thursday that it has completed the confirmatory clinical trial of its skin cancer image detection and diagnostic assistance software, a medical artificial intelligence solution that detects skin cancer.The clinical trial was a multi-center, retrospective study to prove the clinica
The management conflict between Hanmi Science, the Hanmi Pharmaceutical Group holding company, and Lim Jong-yoon, the eldest son of the late founder and president of Hanmi Pharmaceutical, is deepening.After Hanmi Science criticized Lim, the latter hit back."Hanmi Pharm's public relations team claims
The Korea National Enterprise for Clinical Trials (KoNECT) will co-host the "Global Investment Attraction Strategy Seminar for Korean Biotech Firms" with Harvest integrated Research Organization (HiRO) on March 28.The seminar will be held for the first time to provide networking with global investor
Celltrion is expanding its market presence in Peru, a key Latin American market, with successful public tender wins.Celltrion’s Truxima 500mg (rituximab) won the tender for the Peruvian Ministry of Health (Centro Nacional de Abastecimiento de Recursos Estratégicos en Salud, CENARES), the largest pub
Dong-A ST and IMBiologics said they have entered into a research collaboration agreement to develop a novel antibody drug candidate.The collaboration involves IMBiologics deploying its ePENDY (enhanced/engineered Pentamer body) platform technology.Unlike the conventional IgG antibody-based modalitie